日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reply to correspondence on "Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway"

回复关于“基于分区代谢特征和致癌信号通路的肝细胞癌分子分型”的来信

Jang, Eun Ji; Sung, Pil Soo

A novel link between tumor cell metabolism and patient prognosis: Editorial on "Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway"

肿瘤细胞代谢与患者预后之间的新联系:关于“基于分区代谢特征和致癌信号通路的肝细胞癌分子分型”的社论

Jang, Eun Ji; Sung, Pil Soo

Evaluating the clinical utility of large language models for hepatocellular carcinoma treatment recommendations: A nationwide retrospective registry study

评估大型语言模型在肝细胞癌治疗建议中的临床应用价值:一项全国性回顾性注册研究

Yang, Keungmo; Lee, Jaejun; Jang, Jeong Won; Sung, Pil Soo; Han, Ji Won

Liver Stiffness Measured by Vibration-Controlled Transient Elastography Predicts Hepatic Decompensation in Patients with Hepatocellular Carcinoma Receiving Systemic Treatments

振动控制瞬时弹性成像测量的肝脏硬度可预测接受全身治疗的肝细胞癌患者的肝功能失代偿

Lee, Jaejun; Yang, Hyun; Bae, Si Hyun; Cho, Hee Sun; Sung, Pil Soo; Jang, Jeong Won; Yoon, Seung Kew; Yang, Keungmo; Nam, Heechul; Kim, Chang Wook; Lee, Hae Lim; Kim, Hee Yeon; Lee, Sung Won; Lee, Ahlim; Song, Do Seon; Kim, Seok Hwan; Song, Myung Jun; Lee, Soon Kyu; Kwon, Jung Hyun; Nam, Soon Woo; Han, Ji Won

Shelterin Component TPP1 Drives Tumor Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma.

Shelterin 组分 TPP1 驱动肿瘤进展并预测肝细胞癌预后不良。

Jang Jung Eun, Kim Hye Seon, Kim Jin Seoub, Han Jae Mo, Cho Hee Sun, Tak Kwon Yong, Han Ji Won, Sung Pil Soo, Bae Si Hyun, Jang Jeong Won

PNPLA3 I148M is unrelated to HCC occurrence but associates with poorer tumor differentiation in Korean MASLD: a prospective cohort of 562 patients

PNPLA3 I148M 与肝细胞癌的发生无关,但与韩国 MASLD 患者肿瘤分化程度较差相关:一项纳入 562 例患者的前瞻性队列研究

Lee, Jaejun; Lee, Dong Yeop; Cha, Jung Hoon; Cho, Hee Sun; Yang, Keungmo; Yang, Hyun; Byun, Mi Young; Cho, Seok Keun; Yang, Seong Wook; Bae, Si Hyun; Sung, Pil Soo

KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025

KASL 代谢功能障碍相关脂肪肝疾病管理临床实践指南 2025

Sohn, Won; Lee, Young-Sun; Kim, Soon Sun; Kim, Jung Hee; Jin, Young-Joo; Kim, Gi-Ae; Sung, Pil Soo; Yoo, Jeong-Ju; Chang, Young; Lee, Eun Joo; Lee, Hye Won; Choi, Miyoung; Yu, Su Jong; Jung, Young Kul; Jang, Byoung Kuk

Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation

降低慢性肾脏病风险的最佳他克莫司水平以及肝移植后患者体内变异性对慢性肾脏病和终末期肾病发展的影响

Lee, Soon Kyu; Choi, Ho Joong; You, Young Kyoung; Sung, Pil Soo; Yoon, Seung Kew; Jang, Jeong Won; Choi, Jong Young

Male preference for TERT alterations and HBV integration in young-age HBV-related HCC: implications for sex disparity.

男性在年轻 HBV 相关 HCC 中更倾向于 TERT 改变和 HBV 整合:对性别差异的影响

Kim Jin Seoub, Kim Hye Seon, Tak Kwon Yong, Han Ji Won, Nam Heechul, Sung Pil Soo, Lee Sung Won, Kwon Jung Hyun, Bae Si Hyun, Choi Jong Young, Yoon Seung Kew, Jang Jeong Won

Subset of Child-Pugh Score 7 Shows Comparable Survival Outcomes to Child-Pugh Score 6 in Patients with Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab

Child-Pugh 评分 7 分的亚组在接受阿特珠单抗和贝伐珠单抗治疗的肝细胞癌患者中显示出与 Child-Pugh 评分 6 分相当的生存结果

Lee, Jaejun; Yang, Keungmo; Han, Ji Won; Sung, Pil Soo; Jang, Jeong Won; Yoon, Seung Kew; Cho, Hee Sun; Yang, Hyun; Bae, Si Hyun; Kim, Ji Hoon; Nam, Heechul; Kim, Chang Wook; Lee, Hae Lim; Kim, Hee Yeon; Lee, Sung Won; Lee, Ahlim; Song, Do Seon; Song, Myeong Jun; Nam, Soon Woo; Kwon, Jung Hyun; Lee, Soon Kyu